Related by context. All words. (Click for frequent words.) 72 myocardial infarction stroke 67 Erythropoietic therapies may 66 resuscitated cardiac arrest 66 HF hospitalization 65 myocardial infarction ventricular fibrillation 65 recurrent ischemia 64 nonfatal myocardial infarction MI 64 nonfatal myocardial infarction 64 nonfatal MI 64 events MACE 63 recurrent DVT 63 deep venous thromboses 63 unstable angina pectoris 63 recurrent myocardial infarction 62 coronary revascularization procedures 62 nonfatal stroke 62 reinfarction 62 acute coronary syndromes ACS 62 symptomatic intracranial 62 trauma malignant tumors 62 ipsilateral stroke 62 embolic stroke 62 beta blockers ACE inhibitors 62 nonfatal pulmonary embolism 61 repeat revascularization 61 non valvular atrial 61 symptomatic VTE 61 cerebrovascular events 61 myocardial infarction MI 61 seizures miscarriages 61 composite endpoint 61 cardiovascular hospitalization 61 fatal myocardial infarction 61 coronary intervention 61 ischemia driven 61 macrovascular events 60 haematologic 60 binary restenosis 60 revascularisation 60 hemorrhagic complications 60 stroke transient ischemic 60 systemic embolism 60 MACCE 60 refractory ischemia 60 intracerebral hemorrhage ICH 60 XIENCE V demonstrated 60 cardiovascular hospitalizations 60 Venous thromboembolism 60 PLX STROKE targeting 60 postoperative morbidity 59 acute ischemic 59 ischemic cardiovascular 59 undergoing coronary artery 59 postoperative AF 59 bypass graft CABG surgery 59 intraventricular hemorrhage 59 death dissection perforation 59 NYHA Class II 59 acute myocardial infarction AMI 59 thromboembolic 59 ischemic complications 59 proximal DVT 59 thrombo embolic 59 thrombotic events 59 coronary revascularization 58 patients undergoing CABG 58 workhorse lesions 58 TAXUS Express Stent 58 VIIBRYD 58 valvular disease 58 hypertension dyslipidemia 58 apnea hypopnea 58 arterial thromboembolic events 58 peripheral artery 58 nondiabetic patients 58 Acute coronary syndromes 58 neurovascular diseases 58 Warfarin Coumadin 58 periprocedural 58 perioperative mortality 58 unresectable HCC 58 CHD CVD 58 coronary revascularisation 58 revascularizations 58 urgent coronary revascularization 58 unfractionated heparin UFH 58 carotid artery blockage 58 death reinfarction 58 patients undergoing percutaneous 58 echocardiographic parameters 58 distal embolization thrombus formation 57 cerebrovascular accidents 57 severe exacerbations 57 receiving VELCADE 57 Acute Coronary Syndromes ACS 57 tumor lysis syndrome 57 aspirin heparin 57 GP IIb IIIa inhibitors 57 postoperative infections 57 metastatic GIST 57 thrombolytic agents 57 Events MACE 57 ATACAND 57 chronic thromboembolic pulmonary 57 venous thromboembolisms 57 hypervascular tumors 57 extracranial 57 tirofiban 57 acute coronary 57 aplastic anemia AA 57 thromboembolic events 57 plus GP IIb 57 unstable angina UA 57 Coronary artery bypass graft 57 FluCAM arm 57 postoperative mortality 57 fatal pulmonary embolism 57 Infusion Reactions Severe 57 Angiograms carry slight 57 gallbladder disease 57 recurrent venous thromboembolism 57 nadolol 57 antithrombotic agent 57 morbidity mortality 57 Myocardial infarction 57 receiving XGEVA 57 angioplasty stenting 57 pamidronate 57 pericardial effusion 57 decompensated heart failure 57 thromboembolic complications 57 hypertension congestive heart 57 bivalirudin 57 upper gastrointestinal bleeding 57 infarction NSTEMI 57 nonischemic 57 parecoxib 57 heparin induced thrombocytopenia 57 Sezary syndrome 57 lipid lowering agents 56 rebleeding 56 IIIa inhibitor 56 ischemic cardiomyopathy 56 thromboembolic disorders 56 cerebrovascular accident 56 vein thrombosis 56 atrioventricular block 56 anticoagulants blood thinners 56 prespecified secondary 56 atherothrombotic events 56 thromboembolism 56 primidone 56 dyslipidemia hypertension diabetes 56 endarterectomy 56 carotid artery stenting CAS 56 endobronchial 56 syncope fainting 56 severe hepatic dysfunction 56 carotid endarterectomy CEA 56 angina pectoris 56 glycoprotein IIb IIIa inhibitor 56 morphometric vertebral fractures 56 myocardial infarctions 56 discontinuations due 56 percutaneous interventions 56 peripheral arterial occlusive disease 56 intraoperative complications 56 colorectal adenoma 56 neonatal morbidity 56 variceal hemorrhage 56 FRAGMIN 56 AGGRASTAT R tirofiban hydrochloride 56 arterial thromboembolic 56 pulmonary embolism PE 56 macrovascular 56 Atherosclerotic 56 acute myocardial infarctions 56 recombinant tissue plasminogen 56 headache nasopharyngitis 56 cardiac dysfunction 56 treat brain aneurysms 56 decubitus ulcers 56 neutropenia thrombocytopenia 56 TMP SMX 56 aspirin clopidogrel 56 interstitial pneumonitis 56 hepatic failure 56 generalized edema 56 VT VF 56 UA NSTEMI 56 noncardiovascular mortality 56 VTE prophylaxis 56 ischemic cardiac 56 Hemorrhagic stroke 56 LOVENOX 56 progressive dyspnea 56 NATRECOR R 56 fibrinolysis 56 TAXUS p value 56 sirolimus eluting stents 56 angiographic outcomes 56 de ath 56 ARCOXIA 56 NSTE ACS 55 coronary vascular 55 sirolimus eluting 55 variant angina 55 multivessel disease 55 EFFEXOR XR 55 deep vein thromboses 55 TAXUS Stent 55 intracerebral haemorrhage 55 electrolyte abnormalities 55 subarachnoid hemorrhage SAH 55 pioglitazone HCl 55 oral antidiabetic medication 55 pulmonary artery banding 55 hyperphenylalaninemia HPA due 55 occlusive disease 55 CIMZIA TM certolizumab pegol 55 Daytime sleepiness 55 liver decompensation 55 NMIBC 55 carotid artery stenosis 55 antiarrhythmic drug 55 atherothrombotic 55 undergoing CABG 55 anticoagulant medications 55 thromboprophylaxis 55 silent ischemia 55 everolimus eluting stents 55 pulmonary resection 55 percutaneous transluminal coronary angioplasty 55 postoperative bleeding 55 leucopenia 55 Unstable Angina 55 endometrial hyperplasia 55 extrapyramidal symptoms 55 hepatorenal syndrome 55 Uncontrolled hypertension 55 β blockers 55 Acute Myocardial Infarction 55 locoregional recurrence 55 AGGRASTAT ® tirofiban hydrochloride 55 gastrointestinal perforation 55 valvular heart disease 55 coronary stenosis 55 peripheral sensory neuropathy 55 diabetic acidosis 55 recurrent coronary 55 acutely decompensated congestive heart 55 DES implantation 55 thrombophlebitis 55 mucosal inflammation 55 nasopharyngitis headache 55 Thrombolysis 55 acute coronary syndrome 55 ventricular tachycardia VT 55 intima media thickness 55 LV dysfunction 55 angioplasties stents 55 Myocardial Infarction Study 55 infarctions 55 ezetimibe simvastatin 55 ARIXTRA 55 thromboembolic disease 55 renal insufficiency 55 Diabetic nephropathy 55 diastolic blood pressures 55 systemic corticosteroid 55 metformin sulfonylurea 55 Renal impairment 55 venous thromboembolic events 55 tamoxifen Nolvadex ® 55 Hypotension 55 Menopausal hormone therapy 55 nicardipine 55 Thromboembolism 55 complement inhibitor eculizumab 55 metabolic acidosis 55 atherosclerotic cardiovascular 55 Acute Coronary Syndrome 55 alpha interferons 55 gastrointestinal GI motility disorders 55 salmeterol fluticasone 55 atrioventricular valve 55 neutropenia dehydration dyspnea 55 intracranial stenosis 55 prolonged QT interval 55 infusional 55 VTEs 55 Hip fracture 55 prostate TURP 54 inhospital 54 mm Stent 54 bivalirudin monotherapy 54 CNS systemic embolism 54 ischemic cerebrovascular 54 metastatic malignant 54 benazepril 54 COPD exacerbation 54 hematuria abrupt 54 neurologic complications 54 severe hypoglycemic 54 wound dehiscence 54 Thalomid ® 54 Known hypersensitivity 54 acute cholecystitis 54 rosiglitazone maleate 54 ischemic vascular 54 obstructive CAD 54 noncardiac 54 intimal hyperplasia 54 Percutaneous Coronary Intervention 54 systemic hypotension 54 CV thrombotic 54 stroke hypertension palpitations 54 bivalirudin alone 54 intracranial bleeding 54 venous hypertension 54 restenosis reblockage 54 pyrexia mucositis sepsis febrile 54 spinal cord compression 54 paclitaxel eluting stents 54 serious cardiovascular thrombotic 54 thiazide diuretic 54 postoperative delirium 54 oral hypoglycemic agents 54 antiphospholipid syndrome 54 Ischemic heart 54 events thrombocytopenia neutropenia 54 p = NS 54 overt nephropathy 54 thromboembolisms 54 NSAID associated 54 mesenteric ischemia 54 hypertension diabetes mellitus 54 urgent revascularization 54 Intracerebral hemorrhage 54 stable angina pectoris 54 pulmonary thromboembolism 54 infrapopliteal 54 NATRECOR ® 54 peri procedural 54 headache nausea fatigue 54 Acute myocardial infarction 54 LV ejection fraction 54 subarachnoid haemorrhage 54 postoperative atrial fibrillation 54 acute STEMI 54 bifurcated lesions 54 abnormal lipids 54 pravastatin Pravachol 54 IOP lowering 54 coronary artery bypass graft 54 ST Segment Elevation 54 intracerebral hemorrhage 54 anaphylactoid 54 thromboses 54 postoperative pulmonary 54 esophagogastric 54 Severe hypoglycemia 54 recurrent ischemic 54 Postmenopausal hormone therapy 54 variceal 54 nausea vomiting constipation 54 lopinavir r arm 54 drug eluting stent implantation 54 fibroids endometriosis 54 Postoperative complications 54 Operative mortality 54 landmark ATHENA trial 54 anticoagulant warfarin 54 Acute Coronary Syndromes 54 HeFH 54 carotid atherosclerosis 54 LVSD 54 ACTOS ® 54 PAOD 54 CVD mortality 54 target vessel revascularization 54 Estrogen deficiency 54 Renal dysfunction 54 nonfatal cardiac arrest 54 Taxus Stent 54 Thal Dex 54 irbesartan 54 arterial thrombosis 54 cytoreductive surgery 54 mechanically ventilated patients 54 dalteparin 54 Coronary Artery Bypass Graft 54 cardiovascular morbidity 54 antiplatelet medication 54 neutropaenia 54 plus glycoprotein IIb 54 % CI #.#-#.# [008] 54 capillary leak 54 dysrhythmias 54 nasal polyposis 54 rosuvastatin #mg 54 arterial revascularization 54 mediastinitis 54 oral levofloxacin 54 liver metastasis 54 Heavy snorers 54 induce orthostatic hypotension 54 atherothrombotic disease 54 secondary hyperparathyroidism 54 cerebral vascular 54 stenoses 54 confirmed CCyR 54 myocardial infarction 54 revascularization procedure 54 primary percutaneous coronary 54 non selective NSAIDs 54 Pulmonary Embolism PE 54 mg BID dose 54 aneurysm ruptures 54 secondary efficacy endpoint 53 subtrochanteric 53 Secondary endpoints included 53 thrombolytics 53 nonvascular 53 cerebral vascular disease 53 cholecystitis 53 symptomatic hyponatremia 53 Nesiritide 53 nodal metastasis 53 undergoing percutaneous coronary 53 nonfatal cardiovascular 53 microvascular disease 53 cardiovascular disease hypertension 53 perioperative complications 53 symptomatic carotid stenosis 53 cardiopulmonary bypass CPB 53 underwent angiography 53 rehospitalization 53 leiomyomas 53 histologic subtype 53 revascularized 53 nocturnal hypoglycemia 53 Coronary artery bypass grafting 53 untreated OSA 53 candesartan cilexetil 53 STEMIs 53 MIs 53 ACUITY trial 53 definite stent thrombosis 53 debulking surgery 53 uncoated stent 53 myocardial infarction congestive heart 53 hypoventilation 53 thrombocytopenic 53 headache abdominal pain 53 TAVR 53 necrotizing pancreatitis 53 Serious anaphylactoid reactions 53 unknown etiology 53 revascularization procedures 53 Tasigna prolongs 53 pacemakers implantable cardioverter defibrillatorsHELB 53 multivariate adjustment 53 Stent thrombosis 53 anastomotic devices 53 clopidogrel Plavix 53 enoxaparin 53 CYPHER Stent 53 venous thromboembolic disease 53 myocardial ischemia 53 GP IIb IIIa inhibitor 53 Primary endpoints 53 anthracycline taxane 53 glycoprotein IIb IIIa inhibitors 53 cardiovascular ischemic 53 antithrombotic therapy 53 neutropenia febrile neutropenia 53 interferon gamma 1b 53 chemoradiation therapy 53 ExTRACT TIMI 53 transcatheter closure 53 TOPAMAX ® 53 postsurgical 53 reduce serum phosphate 53 HMG CoA reductase inhibitors 53 pulmonary dysfunction 53 rFVIIa 53 arterial occlusion 53 chronic periodontitis 53 coronary interventions 53 gastroenterology neurology 53 acute coronary syndromes 53 atrial septal defects 53 intracranial atherosclerosis 53 empyema 53 Ischemic 53 nonalcoholic steatohepatitis 53 percutaneous intervention 53 lacunar 53 DVT PE 53 concomitant cardiac 53 osteoarthritis rheumatoid arthritis 53 anemia neutropenia 53 hematologic adverse 53 hemodynamically significant 53 hepatocellular carcinoma liver 53 hypercholesterolaemia 53 breast endometrial 53 malignant neoplasm 53 carotid stenosis 53 atherothrombosis 53 circulatory diseases 53 KIF6 carriers 53 insomnia somnolence 53 macrovascular disease 53 recurrent VTE 53 cerebrovascular adverse 53 hepatic insufficiency 53 paroxetine Paxil 53 fluid overload 53 fractional shortening 53 Ischemic stroke 53 microvascular complications 53 pretest probability 53 hyperglycaemia 53 papilledema 53 hemorrhagic cystitis 53 computed tomography angiography 53 perioperatively 53 cerebral vasospasm 53 simvastatin ezetimibe 53 salmeterol inhalation powder 53 CABG coronary artery 53 artery reclogging 53 comorbid conditions 53 unstable angina 53 smoldering myeloma 53 cystoid macular edema 53 colon perforation 53 percutaneous coronary interventions 53 angina chest 53 incomplete revascularization 53 gastrointestinal GI 53 pericardial effusions 53 torsade de pointes 53 cholelithiasis 53 antiplatelet medications 53 intravascular hemolysis 53 valve implantation 53 arterial thromboembolism 53 venous thromboembolism 53 revascularisation procedures 53 symptomatic NOH 53 intracranial hemorrhage ICH 53 antiplatelet drugs 53 Torsades de Pointes 53 endometrial carcinoma 53 diarrhea dyspepsia 53 aneurysmal 53 artery stenosis 53 constipation nausea 53 milrinone 53 myopathy rhabdomyolysis 53 bone marrow suppression 53 somnolence dizziness 53 hemorrhagic bleeding 53 adjunctive placebo 53 chronic pancreatitis CP 53 dose atorvastatin 53 Holter monitoring 53 left ventricular systolic 53 VTE 53 haemolytic uraemic syndrome 53 Coronary artery calcification 53 dyslipidaemia 53 thrombocytopenia neutropenia 53 nonvertebral fracture 53 dysmenorrhoea 53 hypoxemia 53 Major Adverse Cardiac 53 ventricular tachyarrhythmia 53 TAXUS Express Atom Stent 53 pathologic fracture 52 Gastrointestinal GI 52 wedge resection 52 QVAR R 52 tolvaptan 52 cytopenias 52 dermatologic reactions 52 renal dysfunction 52 preoperative intraoperative 52 hypercholesterolemic patients 52 gastrointestinal perforations 52 oral hypoglycemic agent 52 carotid intima media 52 postpartum haemorrhage 52 elevated fasting glucose 52 antiplatelet agent 52 nadroparin 52 EXJADE 52 artery occlusion 52 transthoracic 52 unstable angina chest 52 hormone receptor negative 52 inotropes 52 postoperative complication 52 antiemetics 52 diabetes mellitus hypertension 52 chemotherapy induced neutropenia 52 Relapsing remitting MS 52 underwent CABG 52 Pulmonary embolism 52 coronary insufficiency 52 malignant neoplasms 52 thyrotoxicosis 52 graft occlusion 52 nausea dizziness vomiting 52 thoracic aortic 52 neutropenic sepsis 52 sirolimus eluting stent 52 defibrillator CRT D 52 gastric cardia 52 invasive candidiasis 52 surgical revascularization 52 variceal bleeding 52 preserved ejection fraction 52 noncoronary 52 debilitating complication 52 myelosuppressive chemotherapy 52 Cypher Stent 52 salmeterol HFA MDI 52 incidence ≥ 52 chronic obstructive lung 52 femoral popliteal 52 venous insufficiency 52 irregular quivering 52 persistent pulmonary hypertension 52 TAXUS stent 52 cardioverter defibrillator 52 cyclophosphamide methotrexate 52 thoracic surgeries 52 ventricular fibrillation VF 52 adverse perinatal 52 urolithiasis 52 anastomotic leak 52 segment binary restenosis 52 Pulmonary edema 52 H2 receptor antagonists 52 postintervention 52 ximelagatran 52 pantoprazole Protonix 52 pulmonary capillary wedge 52 severe mitral regurgitation 52 Drug eluting stent 52 catheter angiography 52 Carotid endarterectomy 52 oxycodone CR 52 prospectively stratified 52 symptomatic intracranial hemorrhage 52 histologically confirmed 52 thoracoscopic lobectomy 52 TAXUS Liberte Long 52 undergoing coronary angiography 52 beta blocker therapy 52 elevated IOP 52 severe hypersensitivity reactions 52 serum phosphate 52 hypercoagulable 52 unfavorable cytogenetics 52 overt hepatic encephalopathy HE 52 nephrotoxicity 52 Fluid retention 52 diarrhea nausea vomiting 52 recurrent UTI 52 polyp recurrence 52 bronchial hyperresponsiveness 52 thoracentesis 52 coma convulsions 52 left ventricular diastolic 52 CCyR 52 proliferative retinopathy 52 chorioamnionitis 52 target lesion revascularization 52 INTEGRILIN ® 52 gastro esophageal reflux disease 52 intra abdominal abscess 52 prednisone prednisolone 52 arterial thrombotic 52 coagulopathy 52 reoperations 52 NNT = 52 Spiriva Handihaler 52 MI myocardial infarction 52 Bivalirudin 52 proton MR spectroscopy 52 cerebro vascular 52 bowel perforations 52 ADCS CGIC 52 hematological adverse 52 receiving INTRON 52 ADHF 52 hemodynamically stable 52 gross hematuria 52 receiving prophylactic anticoagulation 52 hypoglycemic events 52 bleeding ulceration 52 biliary obstruction 52 paresthesias 52 prasugrel uh prevented 52 drug eluting coronary stents 52 angiographic restenosis 52 cardiovascular 52 venous reflux 52 elevated uric acid 52 serum phosphorous 52 syncopal 52 chronic idiopathic thrombocytopenic purpura 52 recurrent glioblastoma multiforme 52 PREZISTA r arm 52 Aprotinin 52 unfractionated heparin 52 serum triglycerides 52 stent implantation 52 mixed hyperlipidemia 52 STRIDE PD 52 coagulation abnormalities 52 XIENCE V vs. 52 β blocker 52 thiazolidinedione TZD 52 atherosclerosis narrowing 52 myocardial infraction 52 incisional 52 lung resections 52 Meridia sibutramine 52 INTEGRILIN 52 myalgia arthralgia 52 Hyperlipidemia 52 Pioglitazone 52 Secondary endpoints include 52 CYPHER ® Stent 52 atherogenic dyslipidemia 52 venous thromboembolism VTE 52 ST elevation myocardial 52 bacteriuria 52 Aceon 52 elective PCI 52 reintervention 52 Myocardial Infarction 52 pulmonary infiltrates 52 hardened aortic valve 52 intravenous bisphosphonates 52 erythema nodosum 52 desvenlafaxine succinate 52 radiochemotherapy 52 #.#/#.# mmHg [001] 52 coronary revascularizations 52 Abciximab 52 TIA transient ischemic 52 AA Amyloidosis 52 Degenerative disc disease 52 NIASPAN 52 intravesical therapy 52 gastro esophageal reflux 52 periprocedural MI 52 radiotherapy RT 52 severe hypoglycaemia 52 hyperparathyroidism 52 neurosciences orthopedics 52 undergoing cardiac catheterization 52 mcg BID 52 NSTEMI 52 x ULN 52 postoperative chemotherapy 52 CABG surgery 52 hepatic cirrhosis 52 lipid lowering drugs 52 ß blockers 52 emphysema chronic bronchitis 52 cardiac tamponade 51 acute myocardial infarction congestive 51 RAPTIVA 51 GI bleeds 51 anaphylactoid reactions 51 cerebral infarction 51 pancreatic resection 51 acute decompensation 51 nonsignificant 51 nonfasting triglycerides 51 thoracic aortic aneurysms 51 thrombosis 51 Ramipril 51 myocardial infarctions MIs 51 candidemia 51 atrial arrhythmias 51 #mm Hg 51 postprocedure 51 carotid arterial 51 endometriosis ovarian cysts 51 gastrointestinal hemorrhage 51 somnolence sedation 51 peripheral edema 51 CABG surgeries 51 #.#mmHg 51 anticlotting drugs 51 bullous 51 glycated hemoglobin levels 51 cerebral ischemia 51 diameter stenosis 51 CI #.#-#.# [001] 51 recurrent clotting 51 antithrombotic therapies 51 adenoma recurrence 51 DVT prophylaxis 51 preintervention 51 abdominal adiposity 51 #mg/day [001] 51 graft dysfunction 51 hemodynamic instability 51 anaphylactic reactions bronchospasm 51 malperfusion 51 NYHA Class III 51 NSAID induced 51 cardiac morbidity 51 ID TLR 51 cardiac repolarization 51 glycosylated hemoglobin HbA1c 51 pacemaker implantation 51 aneurysmal subarachnoid hemorrhage 51 ABCB1 51 vasospasm 51 angina myocardial infarction 51 concomitant medication 51 flutamide 51 antiplatelet agents 51 Auxilium anticipates 51 AVANDIA 51 systolic hypertension 51 gadobutrol 51 vascular occlusion 51 TEAEs 51 thoracoabdominal 51 reintubation 51 neointimal hyperplasia 51 Index CDAI score 51 mcg kg REBETOL 51 myocardial reperfusion 51 Lactic acidosis 51 gastrointestinal reflux 51 post thrombotic syndrome 51 acute urinary retention 51 idraparinux 51 invasive aspergillosis 51 related hematological toxicity 51 plus gemcitabine 51 metformin Glucophage 51 diabetes dyslipidemia 51 pT3 51 lichen planus 51 prophylactic therapy 51 underwent resection 51 underwent percutaneous coronary 51 intravitreal injections 51 PASI scores 51 stented 51 angioneurotic edema 51 CI #.#-#.# [002] 51 salmeterol fluticasone propionate 51 colon resection 51 antithrombotics 51 ticlopidine 51 malabsorptive 51 angina congestive heart 51 hyperacute 51 antidiabetic drugs 51 intravenous diuretics 51 thrombolytic therapy 51 optic neuropathy 51 Carotid Revascularization Endarterectomy vs. 51 persistency mortality 51 stenting procedures 51 inhospital mortality 51 abnormal uterine bleeding 51 LAGB 51 metformin accumulation 51 Restenosis 51 heparins 51 bypass grafting 51 blindness amputation 51 transurethral resection 51 Skin sterol 51 nephrolithiasis 51 XIENCE V PROMUS Stent 51 coronary artery bypass grafts 51 related bloodstream infections 51 treated nonsurgically 51 CRBSI 51 systemic corticosteroids 51 mcg QD 51 anti thrombotic 51 jugular venous 51 Testosterone deficiency 51 QTc intervals 51 DVT blood clot 51 autonomic dysfunction 51 frequent awakenings 51 sunitinib Sutent 51 1mg dose 51 uncontrolled bleeding 51 torsades de pointes 51 neutropenia anemia 51 deep venous thrombosis 51 confidence interval #.#-#.# 51 suppurative 51 active comparator 51 System IPSS 51 fatal arrhythmic 51 achieved ACR# 51 potassium sparing diuretics 51 angiotensin converting enzyme inhibitor 51 paroxysmal atrial fibrillation 51 liver resection 51 endothelial activation 51 4mg/kg 51 headache nausea diarrhea 51 Peripheral arterial disease 51 vascular abnormalities 51 diarrhea vomiting nausea 51 Target Lesion Revascularization TLR 51 lower extremity amputation 51 thrombotic thrombocytopenic purpura TTP 51 ACE inhibitors beta blockers 51 retinal vein occlusion 51 surgically induced 51 COPD emphysema 51 REYATAZ r arm 51 aldosterone antagonist 51 neuro trauma 51 symptomatic pulmonary embolism 51 patients receiving ERBITUX 51 vertebrobasilar 51 hemoptysis 51 oncologic outcomes 51 cytoreduction 51 aspirin beta blockers 51 abnormal vaginal bleeding 51 stent restenosis 51 Hemorrhagic strokes 51 thrombi 51 bowel resection 51 Endothelial dysfunction 51 mortality morbidity 51 Balloon kyphoplasty 51 polytherapy 51 acarbose 51 Hazard Ratio 51 fluvastatin Lescol 51 atherosclerotic vascular disease 51 infliximab monotherapy 51 adenoidectomy 51 thrombocytopenia anemia 51 distensibility 51 psychiatric comorbidities 51 portal vein thrombosis 51 anticoagulation therapy 51 CABG 51 International Prognostic Scoring 51 oxymorphone ER 51 superficial edema 51 minimally invasive therapies 51 Myocardial Infarction MI 51 events TEAEs 51 preoperative chemotherapy 51 seizures comas 51 thymectomy 51 arteriovenous malformations 51 Acute Decompensated Heart Failure 51 ACTOplus met XR 51 intracranial haemorrhage 51 Arixtra 51 Crohn Disease Activity 51 Doxil ® 51 superficial femoral 51 deferiprone 51 macrovascular complications 51 thienopyridines 51 symptomatic atrial fibrillation 51 MULTAQ 51 sotalol 51 obstructive sleep 51 hyperprolactinemia 51 Radical prostatectomy 51 Atrial flutter 51 diagnostic angiography 51 confirmed thrombotic cardiovascular 51 light headedness dizziness 50 perinatal morbidity 50 PRADAXA #mg 50 reinterventions 50 acute renal